PROTHENA CORP PLC

Prothena CEO‑Designated Insider William Scully Buys 125,000 Shares Amid Stock Dip, Signals Confidence in Alzheimer’s Pipeline

Prothena insider William P. Scully buys 125,000 shares at $8.17, a confidence boost amid a volatile market and growing Alzheimer’s therapy prospects.

PROTHENA CORP PLC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

13/06/2026, 00:15

3 minutes to read

PROTHENA’s Senior Team Bets Big on Future Growth Amid Sharp Market Dip and Social‑Media Surge

Insider options and social‑media buzz signal confidence in Prothena’s Alzheimer’s therapies, yet market volatility remains—read the full analysis for a clear investment outlook.

PROTHENA CORP PLC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

12/06/2026, 22:45

4 minutes to read